Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche Sees 2012 Profit Growth on New Drugs
Bloomberg
Wed, 02/1/12 - 09:04 am
Tags:
Roche, guidance
FDA Approves Roche, Curis Skin-Cancer Drug
TheStreet.com
Mon, 01/30/12 - 03:57 pm
Tags:
Curis, Roche, FDA, skin cancer, Erivedge
What the Roche Bid for Illumina Tells Us About the Future of Genomics
Forbes
Mon, 01/30/12 - 03:53 pm
Tags:
Roche, M&A, Illumina, genomics
The Law Firm of Weiss & Lurie Investigates Illumina Inc.
Yahoo/BusinessWire
Sat, 01/28/12 - 11:24 am
Tags:
Illumina, Roche, M&A, lawsuits
Roche Begins $5.7 Billion Hostile Takeover Offer for Gene Mapper Illumina
Bloomberg
Fri, 01/27/12 - 11:03 am
Tags:
Roche, hostile takeover, Illumina
Illumina adopts poison pill to stave off Roche
Reuters
Thu, 01/26/12 - 02:12 pm
Tags:
Illumina, Roche, poison pill, M&A, hostile bid
Roche’s Illumina Bid May Spur Buying in DNA Test Land Grab
Bloomberg
Thu, 01/26/12 - 11:27 am
Tags:
Roche, Illumina, hostile bid, DNA scanning, Life Technologies, Affymetrix
Roche Patent Case Against Nova Biomedical, Lifescan Revived
Bloomberg
Wed, 01/25/12 - 12:37 pm
Tags:
Roche, patents, Nova Biomedical, LifeScan, JNJ, glucose monitors
Roche Offers $5.7 Billion for Illumina
Bloomberg
Wed, 01/25/12 - 10:25 am
Tags:
Roche, Illumina, hostile bid, M&A
Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says
Bloomberg
Tue, 01/24/12 - 10:57 am
Tags:
Raptiva, settlements, Roche, Genentech, psoriasis
Why Prolor Biotech Is Rising And Other Attractive Prospects
Seeking Alpha
Fri, 01/20/12 - 09:55 am
Tags:
Prolor, Abbott Laboratories, Alnylam, GSK, Merck, Pfizer, Lilly, Roche
Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says
Bloomberg
Wed, 01/18/12 - 05:59 pm
Tags:
Roche, Zelboraf, melanoma, skin cancer
Roche Refuses To Disclose Tamiflu Data: Scientists
Pharmalot
Tue, 01/17/12 - 10:29 am
Tags:
Roche, Tamiflu
Glaxo, Roche Breast-Cancer Treatments Work Better Combined, Study Shows
Bloomberg
Tue, 01/17/12 - 10:27 am
Tags:
GSK, Roche, breast cancer, Tykerb, Herceptin
Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thu, 01/12/12 - 02:11 pm
Tags:
Europe, M&A, patents, GSK, Roche, AstraZeneca, Novartis
Interferon's Role In Flu Control Shouldn't Be Underestimated
Seeking Alpha
Thu, 01/12/12 - 09:11 am
Tags:
interferon, Flu, Hemispherx, Roche, Novavax, Sinovac
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wed, 01/11/12 - 12:58 pm
Tags:
M&A, Roche, Sanofi, Bristol-Myers Squibb, Novartis, Pfizer, Merck
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
Tags:
hepatitis C, Anadys, Roche, Gilead, Pharmasset, Bristol-Myers Squibb, Inhibitex
Galena Biopharma announces FDA approves IND application
Yahoo/Fly on the Wall
Thu, 01/5/12 - 12:38 pm
Tags:
Galena Biopharma, FDA, NeuVax, Herceptin, Roche
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.